Infective endocarditis after TAVR: 4 key findings from a new study of 7,000 patients @SwissTAVI cardiovascularbusiness.com/topics/structu…

Rates, predictors, and prognostic impact of immediate technical success (VARC-3) - insights from BernTAVI Technical failure was associated with a 2-fold increased risk of the composite outcome at 1 year Fup. From @jaccjournals jacc.org/doi/10.1016/j.…

Surgery After TAVR: Waiting a Month or More Not Really Better - data from BernTAVI SwissTAVI medpagetoday.com/cardiology/pci…

In the SCOPE I trial, early differences in procedural outcomes and valve performance between the ACURATE neo and SAPIEN 3 THVs did not translate into differences in clinical outcomes or bioprosthetic valve failure at 3 years in an elderly population at intermediate surgical risk.

Enterococcal colonization of the groin and isolation of enterococci in TAVR-associated IE --> a change in antimicrobial prophylaxis is warranted and should be changed to antimicrobial prophylaxis with a compound that is active against enterococci. authors.elsevier.com/c/1fnpXiVO07NV…

ESC TV On the Road 🚍 at #ACC23 Watch Stephan Windecker as he shares the 3-year outcomes from the Evolut Low Risk Trial

Clinical Outcomes in High‐Gradient, Classical Low‐Flow, Low‐Gradient, and Paradoxical Low‐Flow, Low‐Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation. #AHAJournals @WagenerM1 Stefan Toggweiler Stefan Stortecky ahajrnls.org/3No8Zc5

JAHA; Thomas Pilgrim; @DanielHagemeyer; Christoph Gräni; SwissTAVI

1/2 "Compared to age- and sex-matched population, TAVR patients exhibit higher risk of stroke for up to two years post TAVR" Delighted to share our work from the SwissTAVI registry Stefan Stortecky Taishi Okuno Thomas Pilgrim SwissTAVI JACC Journals doi.org/10.1016/j.jcin…

Bleeding After Transcatheter Aortic Valve Replacement: The Pebble and the Ripple" Sharing our recently published editorial JACC Journals Stefan Stortecky doi.org/10.1016/j.jcin…